Cost-effectiveness comparison of lamivudine plus adefovir combination treatment and nucleos(t)ide analog monotherapies in Chinese chronic hepatitis B patients

Overview of attention for article published in Drug Design, Development and Therapy, March 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review

Article in PharmacoEconomics - Open (August 2019)

Long-Term Outcomes in Chinese Patients with Chronic Hepatitis B Receiving Nucleoside/Nucleotide Analogue Therapy in Real-World Clinical Practice: 5-Year Results from the EVOLVE Study

Article in Antiviral Therapy (August 2019)

Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis.

Article in American Journal of Translational Research (August 2018)